The leading goal was to establish ideal analytical targets by examining human hepatocyte incubation samples with superior-resolution mass spectrometry (HRMS) and to confirm the outcomes in reliable urine specimens and to find out AB-FUBINACA's metabolic balance in human liver microsomes and as opposed hepatocyte and urine outcomes with in silico pr